反応 #6783
ord-a9969a0f2f7a4f47a1fe7d91077a1b28
反応方程式
反応物
試薬
反応条件
後処理
- 1洗浄washed with 50 mL each of 10% aqueous KHSO4, dilute brine, and brine
- 2乾燥dried over Na2SO4
- 3ろ過filtered
- 4濃縮concentrated
- 5workup.DISSOLUTIONThe residue was dissolved in 3 mL CH2Cl2
- 6workup.ADDITIONwas added
- 7温度then warmed to room temperature for 2 hours
- 8workup.ADDITIONTo this was added 50 mL toluene
- 9濃縮the mixture concentrated
- 10workup.DISSOLUTIONredissolved in CH2Cl2
- 11濃縮toluene and concentrated
- 12workup.DISSOLUTIONThe residue was dissolved in 50 mL DMF
- 13濃縮After 64 hours the reaction mixture was concentrated
- 14workup.ADDITIONthe residue diluted with 50 mL EtOAc
- 15洗浄washed with 20 mL each of 10% aqueous KHSO4, dilute brine, and brine
- 16乾燥dried over Na2SO4
- 17ろ過filtered
- 18濃縮concentrated
- 19その他Purification by flash chromatography (1.5×12 cm silica gel, linear gradient 1–9% MeOH/CH2Cl2
実験手順
To a solution of 0.049 g (0.09 mmol) [2-({[((2S)-1-{(2R)-2-[(tert-butoxycarbonyl) amino]-2-cyclohexylethanoyl} pyrrolidin-2-yl)carbonyl]amino} methyl)-4-chlorophenoxy]acetic acid (J. Med. Chem 1998, 41, 3210) in 3 mL DMF was added 0.018 g (0.1 mmol) glycine tertbutyl ester hydrochloride, 0.015 mL (0.1 mmol) triethylamine, 0.014 g (0.1 mmol) HOAt and 0.029 g (0.15 mmol) EDC. After 3 hours the reaction mixture was diluted with 100 mL EtOAc, washed with 50 mL each of 10% aqueous KHSO4, dilute brine, and brine, then dried over Na2SO4, filtered, and concentrated. The residue was dissolved in 3 mL CH2Cl2 and cooled to 0° C. whereupon 1.5 mL trifluoroacetic acid was added and the mixture stirred 30 minutes at 0° C. then warmed to room temperature for 2 hours. To this was added 50 mL toluene and the mixture concentrated, redissolved in CH2Cl2 and toluene and concentrated. The residue was dissolved in 50 mL DMF and to this was added 0.03 mL (0.2 mmol) triethylamine, 0.015 g (0.1 mmol) HOAt and 0.030 g (0.15 mmol) EDC. After 64 hours the reaction mixture was concentrated and the residue diluted with 50 mL EtOAc, washed with 20 mL each of 10% aqueous KHSO4, dilute brine, and brine, then dried over Na2SO4, filtered, and concentrated. Purification by flash chromatography (1.5×12 cm silica gel, linear gradient 1–9% MeOH/CH2Cl2 afforded (6R,20aS)-16-chloro-6-cyclohexyl-2,3,6,7,9,10,18,19-octahydro-1H-pyrrolo[1,2-j][1,4,7,10,13] benzoxatetraazacyclohexadecine-5,8,11,20 (12H,20aH)-tetrone as a white flaky solid. 1H NMR (CD3OD, 400 MHz): δ 7.32 (d, J=2.65 Hz, 1H), 7.24 (dd, J=2.65 and 8.8 Hz, 1H), 7.01 (d, J=8.8 Hz, 1H), 4.75 (d, J=14.0 Hz, 1H), 4.69 (d, J=14.3 Hz, 1H), 4.60 (d, J=14.3 Hz, 1H); 4.45 (dd, J=3.2 and 8.5 Hz, 1H), 4.3 (d, J=9.97 Hz, 1H), 4.15 (d, J=15.6 Hz, 1H), 4.13 (d, J=14.0 Hz, 1H), 3.97 (m, 1H), 3.73 (d, J=15.6 Hz, 1H), 3.61 (m, 1H), 2.16 (m, 1H), 2.08 (m, 1H), 2.0–1.88 (m, 3H), 1.8–1.6 (m, 5H), 1.58 (m, 1H), 1.28 (m, 2H), 1.04 (m, 1H); exact mass calculated for C24H31C1N4O5: 491.2056 found 491.2067. Analytical HPLC (Zorbax SB-C18 4.6×75 mm, 5% to 95% CH3CN in 0.1% aqueous H3PO4):>99% at 215 nm.